Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation. [electronic resource]
Producer: 20130820Description: 212-23 p. digitalISSN:- 2159-8290
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- metabolism
- Bone and Bones -- drug effects
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cells, Cultured
- Diphosphonates -- administration & dosage
- Humans
- Imidazoles -- administration & dosage
- Inhibitor of Apoptosis Proteins -- antagonists & inhibitors
- Macrophages -- cytology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Nude
- Molecular Structure
- Oligopeptides -- administration & dosage
- Osteoclasts -- cytology
- Osteoporosis -- chemically induced
- Xenograft Model Antitumor Assays
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.